Welcome to our dedicated page for Adient plc SEC filings (Ticker: ADNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Adient plc filings document the reporting, governance and financing disclosures of an Irish automotive seating supplier. Form 8-K reports furnish quarterly and fiscal-year results, non-GAAP reconciliations, investor presentation materials and risk language tied to vehicle production, costs, capital markets, debt levels and cash flow. Material-event reports also disclose amendments to secured term loan and revolving credit facilities involving Adient US LLC, Adient Global Holdings and other subsidiaries.
Proxy filings and annual-meeting 8-Ks cover director elections, shareholder voting results, executive compensation, incentive plans and restricted stock unit awards. The record also documents secured guarantees by the parent and material wholly owned restricted subsidiaries, capital-structure obligations and other governance matters relevant to Adient's public-company status.
Hotchkis and Wiley Capital Management, LLC filed an amendment to Schedule 13G reporting beneficial ownership of 3,251,560 ordinary shares of Adient plc, equal to 3.87% of the class. The filing states HWCM has sole dispositive power over 3,251,560 shares and sole voting power over 2,908,460 shares, with no shared voting or dispositive power reported. HWCM is identified as a Delaware investment adviser with a principal business address in Los Angeles. The filing includes a certification that the shares are held in the ordinary course of business and not for the purpose of changing control. The report is signed by Tina H. Kodama, Chief Compliance Officer, dated 08/13/2025.
Adient plc disclosed that representatives will hold meetings with certain investors in August 2025 and furnished the investor presentation used at those meetings as Exhibit 99.1 to this Form 8-K. The company states the presentation is furnished and therefore not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except where expressly stated. The filing identifies Adient ordinary shares (par value $0.001) trading as ADNT on the New York Stock Exchange and lists the Inline XBRL cover page as Exhibit 104.
Jerome J. Dorlack, who is listed as President and CEO and a director of Adient plc (ADNT), reported a sale of ordinary shares on 08/07/2025. The filing discloses a disposition of 12,000 ordinary shares at a weighted average price of $22.77 per share, with sale prices ranging from $22.76 to $22.90. Following the reported transaction, the reporting person beneficially owned 441,025 shares on a direct basis. No derivative securities were reported on this form. The Form 4 was signed by an attorney-in-fact, Brett L. Eilander, on 08/08/2025.
Adient plc submitted a Form 144 disclosing a proposed sale of 12,000 common shares acquired as restricted stock units on 11/18/2022. The shares are to be sold through Oppenheimer & Co. Inc. on the NYSE with an approximate aggregate market value of $271,119.00 and total shares outstanding listed as 81,245,928. The filing shows no securities sold by the reporting person in the past three months. The notice includes the signer’s representation that they are not aware of any undisclosed material adverse information about the issuer.
Form 8-K (Item 2.02): On 6 Aug 2025 Adient plc (ADNT) disclosed that it has furnished, rather than filed, a news release detailing results for the fiscal third quarter ended 30 Jun 2025. The release is provided as Exhibit 99.1 and is expressly incorporated into this report only by reference. No revenue, EPS, margin or guidance figures appear in the filing itself; investors must review Exhibit 99.1 to obtain the underlying financial data. The company also supplied the customary Exhibit 104 cover-page XBRL file.